ConditionInfections
Diphtheria
Diphtheria is a serious bacterial infection caused by toxin-producing strains of Corynebacterium diphtheriae. It usually affects the throat and nose, forming a thick gray coating (pseudomembrane) that can block breathing, and its toxin can damage the heart and nerves. It spreads through droplets and close contact. Diphtheria is now rare in countries with high vaccination rates, but outbreaks still occur. It is a medical emergency treated with diphtheria antitoxin and antibiotics, and it is prevented by the DTaP and Tdap vaccines.
Also called: Respiratory diphtheria, cutaneous diphtheria, Corynebacterium diphtheriae infection
At a glance
- What it is
- An infection by toxin-producing Corynebacterium diphtheriae, usually of the throat.
- Key sign
- A thick, gray, adherent membrane on the tonsils or throat, with a swollen "bull neck".
- Spread
- Respiratory droplets, close contact, and contact with infected skin sores.
- Treatment
- Diphtheria antitoxin plus antibiotics, in hospital, with isolation.
- Prevention
- DTaP for children, Tdap for preteens, and Td or Tdap boosters every 10 years for adults.
When to get help
Call 911 or go to the ER
- Sore throat with a gray or white coating that bleeds when scraped, and difficulty breathing or swallowing
- Noisy breathing, drooling or a swollen neck in someone unvaccinated or recently in an outbreak area
- Chest pain, palpitations, fainting or breathlessness in the weeks after a throat infection (possible heart damage)
See a doctor within a day or two
- Close contact with a confirmed diphtheria case, even without symptoms, for testing, antibiotics and vaccination
- A non-healing skin ulcer with a gray base after travel to an area where diphtheria is common
- Weakness, double vision, slurred speech or difficulty swallowing weeks after a sore throat
Book a routine appointment
- Being behind on diphtheria-containing vaccines, especially before travel
What causes diphtheria
Corynebacterium diphtheriae is a bacterium that lives in the nose and throat. Some strains carry a gene, delivered by a virus that infects the bacterium, that lets them produce diphtheria toxin. The toxin kills cells locally, forming the membrane, and spreads through the blood to damage the heart, nerves and kidneys. Related species (C. ulcerans, from animals and unpasteurized dairy) can also produce the toxin.
How diphtheria spreads
- respiratory droplets from coughing and sneezing
- close, prolonged contact, such as in the same household
- touching infected skin sores or, less often, contaminated objects
People are usually infectious for up to 2 weeks without treatment, and less than 48 hours after starting effective antibiotics. Some people carry the bacteria without symptoms and can still spread it.
Risk is highest in unvaccinated or under-vaccinated people, crowded living conditions, and areas where vaccination programs have been disrupted.
Symptoms
Symptoms usually begin 2 to 5 days after exposure (range 1 to 10 days).
Respiratory diphtheria
- sore throat and hoarseness
- mild fever and chills
- a thick gray or whitish membrane on the tonsils, throat or nose, which sticks firmly and bleeds if scraped
- swollen lymph glands and soft-tissue swelling in the neck, giving a "bull neck" appearance in severe cases
- difficulty swallowing and breathing, and noisy breathing (stridor)
- a bloody, foul-smelling nasal discharge when the nose is involved
Cutaneous (skin) diphtheria
Shallow, non-healing ulcers with a gray membrane, often on the legs. It is more common in tropical climates and among people experiencing homelessness. It is usually milder but spreads the infection.
Diphtheria vs other sore throats
| Feature | Diphtheria | Strep throat | Mononucleosis |
|---|---|---|---|
| Throat coating | Gray, firmly stuck, bleeds when scraped, may spread beyond tonsils | White or yellow patches, easily removed | White exudate on tonsils |
| Fever | Low-grade | Often high | Moderate |
| Neck swelling | Can be marked ("bull neck") | Tender nodes | Large nodes, especially back of neck |
| Vaccination history | Often unvaccinated | Any | Any |
Complications
- Airway obstruction from the membrane and swelling, the most immediate danger
- Myocarditis: inflammation of the heart muscle, typically 1 to 2 weeks after the start of illness, causing abnormal heart rhythms and heart failure
- Nerve damage (neuropathy): weakness of the palate, eye muscles and limbs, or breathing muscles, appearing weeks after infection
- Kidney damage
Even with treatment, diphtheria remains fatal in about 5% to 10% of cases, higher in young children and older adults.
Diagnosis
Because diphtheria progresses quickly, treatment is started on clinical suspicion without waiting for results. Doctors will:
- take swabs from the throat, nose and beneath the membrane, or from skin lesions, for culture
- test any isolated bacteria for toxin production
- perform an ECG and blood tests to check for heart involvement
Public health authorities must be notified immediately, so close contacts can be traced.
Treatment
- Diphtheria antitoxin (DAT): neutralizes toxin that has not yet entered cells. It is given as early as possible. In the US, it is obtained through the CDC.
- Antibiotics: erythromycin or penicillin to kill the bacteria and stop transmission.
- Hospital care and isolation until two swabs taken 24 hours apart after finishing antibiotics are negative.
- Airway support: sometimes a breathing tube or tracheostomy.
- Heart monitoring for several weeks.
- Vaccination after recovery: the illness does not reliably produce immunity.
Close contacts
Household and other close contacts are swabbed, given preventive antibiotics, and vaccinated if their immunization is not up to date. They are monitored for symptoms for 7 to 10 days.
Prevention: the diphtheria vaccine
Diphtheria toxoid vaccine is given in combination with tetanus and pertussis vaccines:
- DTaP for children: doses at 2, 4, 6 and 15 to 18 months, and 4 to 6 years
- Tdap at 11 to 12 years
- Td or Tdap boosters every 10 years for adults
- Tdap during each pregnancy, ideally at 27 to 36 weeks, mainly to protect newborns from whooping cough
The vaccine protects against the toxin, preventing severe disease. Check your vaccination status before traveling to regions with ongoing diphtheria.
Frequently asked questions
What are the symptoms of diphtheria?
Diphtheria typically starts with a sore throat, mild fever and swollen neck glands. A thick, gray membrane forms on the tonsils or throat and can make breathing and swallowing difficult. The toxin can later affect the heart and nerves.
How is diphtheria spread?
It spreads through droplets from coughs and sneezes, close contact with an infected person, and contact with infected skin sores. People without symptoms can carry and spread the bacteria.
Is diphtheria still around?
Yes. It is rare in countries with high vaccination coverage, but outbreaks continue in parts of Asia, Africa and elsewhere, especially where vaccination rates have fallen. Travelers should ensure their vaccines are up to date.
How is diphtheria treated?
Diphtheria is treated in hospital with diphtheria antitoxin to neutralize the toxin and antibiotics to kill the bacteria. Patients are isolated, the airway and heart are closely monitored, and close contacts receive preventive antibiotics and vaccination.
Sources
This guide was written from current patient and clinical guidance, including:
- CDC: Diphtheria: Clinical overview and vaccination
- CDC Pink Book: Epidemiology and Prevention of Vaccine-Preventable Diseases: Diphtheria
- World Health Organization: Diphtheria fact sheet
- MedlinePlus: Diphtheria
- UK Health Security Agency: Public health control and management of diphtheria